T1	Participants 16 51	large bowel carcinoma--fluorouracil
T2	Participants 259 311	advanced measurable metastatic large bowel carcinoma
T3	Participants 335 387	6/32 (19%) for FU + HU and 5/32 (16%) for MOF-Strep;
T4	Participants 556 577	patients who received
